Pharmala Biotech Holdings Inc at OTC Markets Life Science Investor Forum Transcript
Hello, and welcome to Virtual Investor Conferences. My name is Cecilia. And on behalf of OTC Markets, we're very pleased to have joined us for our next live presentation from PharmAla Biotech. This is a biotech company focused on the research development and manufacturing of MDXX class molecules, including MDMA.
Please note, you can submit questions in the question box to left of the slides. You can also view company's availability for one-on-one meetings through the scheduled meetings tab found on the conference platform.
At this point, I'm very pleased to welcome Nicholas Kadysh, founding CEO and President; Shane Morris, Chief Operations Officer; and Harpreet Kaur, Vice President of Research of PharmAla Biotech, which trades on the OTC Markets under the symbol PMBHF, and on the CSE under the symbol MDMA.
Welcome, Nicholas, Shane, and Harpreet.
Thank you very much. It's a pleasure to be here. I'm Nick
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
